Related Experiment Video
Updated: Mar 10, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
USP1 promotes hepatocellular carcinoma progression by modulating mitophagy via stabilizing MCM3 to regulate the
Zhonge Chen1,2, Chengqin Sun1,2, Ye Wang3
1Department of Gastroenterology, The Affiliated Hospital of Guizhou Medical University, No.28 Gui Medical Street, Yunyan District, Guiyang, Guizhou 550004, China.
Abstract:
Hepatocellular carcinoma (HCC) is a common malignant tumor with a high mortality rate. High mitophagy levels can promote hepatic tumor progression; therefore, inhibiting mitophagy may be a promising therapeutic strategy. This study shows that minichromosome maintenance protein 3 (MCM3) was upregulated in HCC. Knocking down MCM3 suppressed the biological behaviors of tumor cells, promoted tumor cell apoptosis, and inhibited mitophagy. We found that USP1 binds to MCM3 and stabilizes it via deubiquitination of K48-linked ubiquitin chains. Excessive MCM3 proteins bind to Keap1, disrupting the Keap1-Nrf2 interaction and activating the Nrf2 signaling pathway to modulate mitophagy, promoting HCC progression. In addition, our in vivo experiments showed that MCM3 knockdown significantly suppressed xenograft tumor growth. In summary, MCM3 functions as a key oncoprotein. USP1-mediated deubiquitination of MCM3 influences the Keap1-Nrf2 axis, regulates mitophagy, and facilitates HCC progression. MCM3 may be a potential therapeutic target for liver cancer.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Induced Pluripotent Stem Cells
Somatic...
